Gyre Therapeutics (GYRE) Interest Coverage Ratio (QoQ) (2010 - 2020)
Gyre Therapeutics (GYRE) Interest Coverage Ratio (QoQ) (2010 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
| Date | Value |
|---|
| Dec 31, 2020 |
88.46% |
| Dec 31, 2014 |
-82.95% |
| Sep 30, 2014 |
11.06% |
| Jun 30, 2014 |
-77.94% |
| Mar 31, 2014 |
84.45% |
| Dec 31, 2013 |
-31.60% |
| Sep 30, 2013 |
-13.37% |
| Jun 30, 2013 |
-72.49% |
| Mar 31, 2013 |
42.75% |
| Dec 31, 2012 |
-123.10% |
| Sep 30, 2012 |
-162.58% |
| Jun 30, 2012 |
747.03% |
| Mar 31, 2012 |
124.85% |
| Dec 31, 2011 |
-28.49% |
| Sep 30, 2011 |
-169.87% |
| Jun 30, 2011 |
-122.34% |
| Mar 31, 2011 |
1,240.51% |
| Dec 31, 2010 |
-148.95% |
| Sep 30, 2010 |
-45.60% |
